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Abstract. 
 
Desmogleins are desmosomal cadherins that
mediate cell–cell adhesion. In stratiﬁed squamous epi-
thelia there are two major isoforms of desmoglein, 1 and
3, with different distributions in epidermis and mucous
membrane. Since either desmoglein isoform alone can
mediate adhesion, the reason for their differential distri-
bution is not known. To address this issue, we engineered
transgenic mice with desmoglein 3 under the control of
the involucrin promoter. These mice expressed desmo-
glein 3 with the same distribution in epidermis as found
in normal oral mucous membranes, while expression of
other major differentiation molecules was unchanged.
Although the nucleated epidermis appeared normal, the
epidermal stratum corneum was abnormal with gross
 
scaling, and a lamellar histology resembling that of nor-
mal mucous membrane. The mice died shortly after
birth with severe dehydration, suggesting excessive
transepidermal water loss, which was conﬁrmed by in
vitro and in vivo measurement. Ultrastructure of the
stratum corneum showed premature loss of cohesion of
corneocytes. This dysadhesion of corneocytes and its
contribution to increased transepidermal water loss was
 
conﬁrmed by tape stripping. These data demonstrate
that differential expression of desmoglein isoforms
affects the major function of epidermis, the permeabil-
ity barrier, by altering the structure of the stratum
corneum.
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Introduction
 
Desmogleins and desmocollins are transmembrane glyco-
proteins of the desmosome, a cell–cell adhesive structure
 
prominent in epithelial tissues (Garrod et al., 1999). Both gly-
coproteins exist in three isoforms encoded by separate genes.
Several lines of evidence suggest that these glycopro-
 
teins are critical for the cell–cell adhesion function of
the desmosome. First, desmogleins and desmocollins are
members of the cadherin gene superfamily, of which the
prototypic members (e.g., E-cadherin) mediate adhesion.
Second, in some systems, transfection of desmosomal cad-
herins with plakoglobin, an intracellular plaque protein of
the desmosome, confers adhesive properties to cells
(Tselpsis et al., 1998). Finally, antidesmoglein antibodies
in pemphigus cause a loss of keratinocyte cell adhesion
(Mahoney et al., 1999).
Although both desmogleins and desmocollins may be
needed for adequate cell adhesion, why there are different
isoforms of each in different layers of the same tissue is
 
not clear. For example, desmoglein (Dsg)
 
1
 
 1 is expressed
 
throughout all the nucleated cell layers of the epidermis,
but Dsg 3 is found only in the deep epidermis, whereas in
oral mucous membrane Dsg 3, like Dsg 1, is found
throughout all the nucleated cell layers (Amagai et al.,
1996; Shirakata et al., 1998). It is unlikely that this tissue-
specific distribution of Dsg isoforms is critical for adhesion
in the living layers of the epidermis, at least in skin not un-
der stress, because recent evidence suggests that either Dsg
1 or Dsg 3 alone is adequate for cell–cell adhesion. For in-
stance, Dsg 1 alone provides adequate cell adhesion in the
superficial nucleated cell layers of the epidermis, even
though it is the only Dsg expressed at that level. Further-
more, since superficial blisters do not occur within the skin
or mucous membranes of Dsg 3 knockout mice, Dsg 1 suf-
fices for adhesion in the superficial epithelium (Koch et al.,
1997). Finally, we recently showed that Dsg 3 can substi-
tute for loss of Dsg 1–mediated adhesive function induced
by passive transfer of anti–Dsg 1 pemphigus foliaceus anti-
bodies (Wu et al., 2000). Therefore, Dsg 1 or Dsg 3 alone
can provide adequate cell adhesion in normal epidermis.
One explanation for the variable distribution of desmo-
glein isoforms in different epithelia might be to provide
adhesion that is appropriate for the specific types of stress
to which these epithelia are subjected. However, another
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possibility is that there are functions of desmogleins be-
yond simple adhesion. Accordingly, we hypothesized that
the differential distribution of desmoglein isoforms might
influence the differentiation and/or function of these epi-
thelia. To test this hypothesis, we constructed a transgenic
mouse in which the distribution of Dsg 3 in epidermis was
similar to that in oral mucous membranes. In these mice,
the epidermal stratum corneum displayed some properties
that resembled those of the stratum corneum in mucosal
epithelia, including histological features, decreased cohe-
sion, and increased transepidermal water loss that often re-
sulted in lethality during the first week of life due to dehy-
dration. These results demonstrate that the distribution of
desmoglein isoforms in stratified squamous epithelia regu-
lates both the structure and function of these epithelia.
 
Materials and Methods
 
Construction and Genotyping of Involucrin-Dsg 3 
Transgenic Mouse
 
The involucrin promoter vector (pH3700-pL2), which also contained the
first involucrin intron, an SV40 intron, a 
 
b
 
-galactosidase gene, and an
SV40 polyadenylation site, was a gift from Dr. Lorne Taichman (State
University of New York at Stony Brook, Stony Brook, NY; Carroll and
Taichman, 1992). Mouse cDNA encoding Dsg 3 was cloned as previously
described (Ishikawa et al., 1994, 2000; Wu et al., 2000) (Genbank
U86016). PCR of the 3
 
9
 
 end was used to add 27 nucleotides that encode
the FLAG octapeptide epitope. The final sequence was confirmed by nu-
cleotide sequencing. The 
 
b
 
-galactosidase gene was removed from
pH3700-pL2 by digestion with restriction enzyme NotI and replaced with
the mouse Dsg 3-FLAG cDNA. The transgene (containing the involucrin
promoter and mouse Dsg 3-FLAG) was excised from the involucrin cas-
sette with SalI and microinjected into the male pronuclei of B6SJLF1/J
mice zygotes before implantation into pseudopregnant foster CD-1 mice.
Mouse tail DNA, extracted with Puregene Genomic DNA Isolation Kit
(Gentra Systems), was used for PCR and Southern blotting to establish
genotypes. PCR primers from desmoglein 3 exon 7 (5
 
9
 
-AACTTC-
CCAGTGCTCAGAGAGTCTC-3
 
9
 
) and exon 8 (5
 
9
 
-TTAACCACCT-
TCAGGATGCCTTC-3
 
9
 
) were used to identify genomic DNA (671-bp
product) or transgenic cDNA (213-bp product) (see Fig. 1 B). Southern
blotting was performed with a digoxigenin-dUTP–labeled probe gener-
ated by PCR of mouse Dsg 3 cDNA with primer sets starting at nucleotide
positions 976 and 1497 (5
 
9
 
-GAAGGCATCCTGAAGGTGGT-3
 
9
 
 and 5
 
9
 
-
CTTCTCGAGGACAACTGACG-3
 
9
 
), according to the PCR DIG probe
synthesis kit (Boehringer). Genomic DNA was digested with HindIII,
electrophoresed, and transferred to MagnaGraph nylon membranes (Os-
monics), and then, after hybridization and washing, was incubated with
horseradish peroxidase–conjugated antidigoxygenin antibody and devel-
oped with a chemiluminescence substrate (CSPD; Boehringer).
 
Antibodies 
 
A rabbit affinity-purified antibody against extracellular domain 5 of
mouse Dsg 3 (Koch et al., 1998) and a rabbit anti–FLAG epitope antibody
(Zymed Laboratories) were used for indirect immunofluorescence.
Rabbit antisera against extracellular domain 5 of Dsg 3 and Dsg 1 were
used for immunoblotting, as was a mouse monoclonal anti–FLAG anti-
body (Eastman Kodak Co.). The rabbit anti–mouse Dsg 3 antiserum
against extracellular domain 5 of Dsg 3 was prepared as described (Koch
et al., 1998). (The same antiserum was used to prepare the affinity-puri-
fied antibody described above.) The rabbit antiserum against extracellular
domain 5 of Dsg 1 was prepared similarly.
Rabbit antibodies against loricrin, involucrin, filaggrin, and keratin 10
were obtained from Babco.
 
Immunofluorescence and Immunoblotting
 
Indirect immunofluorescence of formalin-fixed mouse skin with rabbit an-
tibodies was performed as previously described (Wu et al., 2000). Rabbit
IgG was detected with Texas red–conjugated (Molecular Probes) or Cy
 
3
 
-
conjugated (Jackson ImmunoResearch Laboratories) goat anti–rabbit IgG.
 
For immunoblotting, mouse back skin or mucous membrane (tongue)
was homogenized on dry ice, and then extracted with Laemmli sample
buffer. Samples with equal protein amounts (Protein Assay Kit; Bio-Rad
Laboratories), were electrophoresed on 6% Tris-glycine polyacrylamide
gels (Novex), and then transferred to nitrocellulose sheets (Trans-Blot;
Bio-Rad Laboratories). The sheets were incubated for 1 h in blocking
buffer [5% fat-free milk powder in 50 mM Tris-HCl, pH 7.4, 150 mM
NaCl (TBS)]. The first antibody, diluted in blocking buffer, was then ap-
plied for 1 h at room temperature. After two washes with 0.1% Tween-20
in TBS (anti–FLAG) or 0.5% Triton X-100, 0.5 M NaCl in TBS (anti–
Dsg), the sheets were incubated for 2 h with horseradish peroxidase–con-
jugated anti–rabbit or anti–mouse IgG (Bio-Rad Laboratories) diluted
1:1,000 in blocking buffer. After washing with 0.1% Tween-20 in TBS, the
signals were detected with chemiluminescence (ECL; Amersham Pharma-
cia Biotech). Signals were quantitated by densitometry with ImageQuant
software (Molecular Dynamics).
 
Transepidermal Water-loss Measurement
 
6-mm punch biopsies, taken from the flank skin of 3–8-d-old transgenic
pups and normal littermates, were placed in silicone high vacuum grease
(Dow Corning) dermal side down on parafilm, and then weighed every 30
min (Hanley et al., 1996). The grease covered all exposed dermal surfaces
so that water loss would only be through the epidermis.
We also used an electrolytic water analyzer (Meeco) to measure tran-
sepidermal water loss of 6-d-old pups from three sites (both shoulders and
left hip), as previously described (Menon et al., 1985).
 
Electron Microscopy
 
Skin samples, fixed in Karnovsky’s fixative, were analyzed as previously
described (Hou et al., 1991).
 
Corneocyte Tape Stripping 
 
D
 
-Squame disks (CuDerm Corp.) were used to strip stratum corneum
cells as previously described (Dreher et al., 1998); however, instead of
the Bio-Rad protein assay, we used the Bradford protein assay (Brad-
ford, 1976).
Figure 1. Genotyping of involucrin-Dsg 3 transgenic mice. (A)
Transgenic construct. Inv, involucrin; mDsg3, mouse Dsg 3;
FLAG, indicates nucleotides encoding the FLAG peptide
epitope; polyA, polyadenylation signal. NotI shows restriction
sites used to clone the mDsg 3-FLAG cDNA into the pH3700-
pL2 parental vector. (B) PCR strategy to differentiate the trans-
gene from the genomic mouse Dsg 3 DNA. (Arrows) Position of
primers, (gray rectangles) exons, (black line) intron. Tg, trans-
gene. (C) PCR analysis of transgenic mouse (1) compared with
nontransgenic (2) littermate. (Arrowhead) 671-bp genomic
PCR product, (arrow) 213-bp transgene product. (D) Southern
blot detects transgene (arrow) and genomic DNA (arrowhead). 
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Results
 
Genetic and Expression Analysis of Involucrin-Dsg 3 
Transgenic Mice
 
To determine whether different distributions of desmoglein
isoforms affect the structure or function of epidermis, we en-
gineered a transgenic mouse expressing mouse Dsg 3 in epi-
dermis in the pattern normally found only in mucous mem-
branes. The transgene placed mouse Dsg 3 cDNA under the
control of the involucrin promoter (Fig. 1 A). Nucleotides en-
coding the FLAG peptide sequence, which can be detected
with specific antibodies, were added to the 3
 
9
 
 end of the cod-
ing sequence. Since involucrin is expressed normally in the
suprabasilar layers of epidermis (Rice and Green, 1979; Car-
roll et al., 1993), this transgenic mouse would be expected to
express Dsg 3 in both the deep epidermis (from the normal
 
gene) and the more superficial epidermis (from the trans-
gene). Two independent transgenic mouse lines were ob-
tained, and both showed essentially identical findings.
Analysis by PCR with primers in exons 7 and 8 of mouse
Dsg 3 DNA identified a germline band of 671 bp, com-
pared with a band from the transgene cDNA of 213 bp,
clearly differentiating the transgenic mouse from the non-
transgenic littermate (Fig. 1, B and C). This genotyping
was confirmed by Southern blotting (Fig. 1 D), which
showed a copy number for the transgene of 
 
z
 
47 and 51,
respectively, in the first and second founders’ lines.
Expression of the transgene was detected by Western
blotting for the FLAG-tagged mouse Dsg 3 of extracted
skin from transgenic neonatal mice (Fig. 2 A). Distribu-
tion of expression of the transgenic mouse Dsg 3-FLAG
was detected by immunofluorescence with anti–FLAG an-
tibodies of mouse skin, which showed cell-surface staining
in the suprabasilar layers of the epidermis (Fig. 2 B). The
distribution of both transgenic and nontransgenic Dsg 3 in
mouse skin was detected by immunofluorescence with an
anti–mouse Dsg 3 antibody. Whereas nontransgenic litter-
mates showed Dsg 3 only in the deep epidermis (Fig. 2 C),
transgenic animals showed Dsg 3 throughout the entire
epidermis (Fig. 2 D), in a pattern identical to that de-
scribed in oral mucous membrane (Mahoney et al., 1999).
To determine the approximate ratios of Dsg 3 to Dsg 1 in
transgenic skin compared with normal mucous membrane,
we quantitated the band intensities of Western blots (Fig. 2
E). These data showed that the ratio of Dsg 3 to Dsg 1 in
transgenic skin of founder 1 was approximately that seen in
normal oral mucous membrane (i.e., tongue), but higher
than that seen in normal epidermis. The ratio of Dsg 3 to
Dsg 1 in the transgenic skin of founder 2 (2.3) was higher
than in founder 1 (1.7), although both showed similar scaling
phenotypes. These data show that the Dsg 3 to Dsg 1 ratio in
transgenic skin more closely resembles that found normal
tongue mucosa than that found in normal epidermis.
 
Involucrin-Dsg 3 Transgenic Mice Show an Abnormal 
Epidermal Stratum Corneum with Histological 
Similarities to Oral Mucous Membrane
 
Although transgenic mice appeared normal at birth, within
2–3 d they developed scaling and were noted to be smaller
than control littermates (Fig. 3 A), even though they had
Figure 2. Analysis of mouse Dsg 3 expression
in transgenic and normal mouse skin. (A) Im-
munoblot with anti–FLAG antibody indicates
expression of mouse Dsg 3-FLAG (arrowhead,
z160 kD) in extract of transgenic (1) mouse
skin. Nontransgenic littermate (2) skin serves
as a control. (B) Immunofluorescence of trans-
genic mouse tail skin for FLAG epitope shows
expression of transgene in suprabasilar area of
epidermis. (C) Immunofluorescence of nontrans-
genic mouse tail for mouse Dsg 3 shows expression
in the basal and immediate suprabasal layer of epi-
dermis. (D) Immunofluorescence of transgenic
mouse tail for mouse Dsg 3 shows expression
throughout the epidermis. (B–D) Original magnification 1003. (E) Immunoblotting for mouse Dsg 3 and mouse Dsg 1 from extracts of
mouse skin and tongue show that transgenic (scaly) epidermis from founder 1 has a Dsg 3/Dsg 1 ratio similar to normal tongue mucous
membrane, whereas transgenic mucous membrane from the same founder expresses excess Dsg 3.
Figure 3. Involucrin-Dsg 3 transgenic mice have an abnormal
stratum corneum. (A) Right two mice are transgenic pups, left
two are normal littermates. Scaling of transgenics indicates an
abnormal stratum corneum (all pups are 6-d old). (B) Histology
(hematoxylin and eosin stain) of nontransgenic tail skin shows
typical basket weave stratum corneum (brackets). (C) Histology
of transgenic tail skin shows normal living epidermis but compact
and lamellar stratum corneum (brackets). (D) Histology of nor-
mal palate shows compact and lamellar stratum corneum, similar
to that seen in the transgenic epidermis (brackets). (B–D) 4-d-old
pups, original magnification 1253. 
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visible milk in their stomachs. The degree of scaling of
transgenic mice was somewhat variable and correlated posi-
tively with the degree of transgene expression, as deter-
mined by Western blotting with anti–FLAG antibody. For
example, while mice heterozygous for the transgene from
the first founder were nonscaling, homozygous mice were
scaling and showed at least twice as much expression of Dsg
3-FLAG by Western blotting. Heterozygous mice from the
second founder showed scaling at age 2–3 d, and Western
blots for Dsg 3-FLAG showed equivalent amounts to that
seen in homozygotes from the first founder. Homozygous
mice from the first founder died by age 7–10 d. Most het-
erozygote mice from the second founder died by 10 d, but
some survived and those that did were able to breed.
Scaly, transgenic mice were killed and autopsied at 4–6 d.
Other than the skin, the histology of all organs and tissues,
including mucous membranes, was normal. The epidermis
showed a strikingly altered stratum corneum (Fig. 3 C).
Compared with the normal stratum corneum of skin,
which typically shows a “basket weave” pattern (Fig. 3 B),
the stratum corneum of the transgenic epidermis was thin-
ner with a compact lamellar pattern, similar to that seen in
normal oral mucous membrane (Fig. 3 D).
 
Involucrin-Dsg 3 Transgenic Mice Demonstrate 
Abnormal Cutaneous Barrier Function 
 
Other than those of the skin, the only abnormalities noted
in the transgenic neonatal mice were a significantly in-
creased hematocrit and serum protein concentration, as
 
well as decreased weight. At age 6–7 d, the hematocrit of
the scaly transgenic mice was 43 
 
6
 
 1.2% (mean 
 
6
 
 SEM,
 
n
 
 
 
5 
 
7), compared with 32 
 
6
 
 0.7% (
 
n
 
 
 
5 
 
7) for normal litter-
mates; the total serum protein of these transgenic mice was
4.1 
 
6
 
 0.1 g/dl (mean 
 
6
 
 SEM), compared with 2.3 
 
6
 
 0.1 g/dl
for normal littermates. The weight of these transgenics was
2.6 
 
6
 
 0.09 g (mean 
 
6
 
 SEM), compared with nontransgenic
littermates of the same age that weighed 3.9 
 
6
 
 0.16 g. This
hemoconcentration, along with excess scale and altered
histology of the stratum corneum, suggested that the trans-
genic mice might have a permeability barrier defect, re-
flected by increased transepidermal water loss leading to
dehydration, decreased weight, and eventual death.
To test this hypothesis, we first isolated 7-d-old trans-
genic and nontransgenic littermates from their mothers
Figure 4. Involucrin-Dsg 3
transgenic mice show in-
creased transepidermal wa-
ter loss. (A) Neonatal mice
were separated from their
mothers and weighed over
time. Transgenic mice (r)
lose weight faster than non-
transgenic littermates (d).
Error bars indicate SEM for
four mice in each group.
Rate of weight loss, mean 6
SEM is shown. (B) Weight
loss of isolated skin from
transepidermal water loss
through the epidermis.
Graphs show paired com-
parison of transgenic mouse
skin (r) and nontransgenic
littermate skin (j). Rate of
transepidermal water loss,
mean  6 SEM for eight sam-
ples in each group is shown.
Figure 5. Dsg 3 in the superficial epidermis of transgenic mice re-
sults in premature dissolution of desmosomes and cleft formation
in the stratum corneum. (A) Dissolution of desmosomes begins at
the stratum granulosum (SG)–stratum corneum (SC) interface.
Desmosomal detachment (single arrows) results in cleft formation
(*) at all levels of the stratum corneum. D, normal-appearing des-
mosomes. (B) Normal-appearing desmosomes in control stratum
corneum. (C) Normal mucous membrane (lip) also reveals early
cleft formation. Note small (small *) clefts at SG–SC interface and
larger clefts (large *) at higher levels. Bar: 0.5 mm (A and B), 1 mm
(C). Osmium tetroxide postfixation. 
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and weighed them for 5 h (Fig. 4 A). In all cases, trans-
genic mice lost weight faster than nontransgenic mice. Pre-
sumably this accelerated weight loss of transgenic mice
could be ascribed to increased transepidermal water loss.
However, it is possible that other fluid loss (e.g., urine)
could have accounted for these differences, although no
other evidence of fluid loss was apparent.
To examine epidermal barrier function directly, we
measured the rate of water loss from the surface of 6-mm
punch biopsies from the skin of transgenic and nontrans-
genic 3–8-d-old mice. We performed paired comparisons
for weight change, as a measure of surface water loss,
over time of a transgenic and nontransgenic skin sample
for each experiment. In each paired comparison (
 
n
 
 
 
5 
 
8),
the transgenic skin displayed higher rates of transcutane-
ous water loss than did the nontransgenic skin (Fig. 4 B
shows two-paired comparison and mean 
 
6
 
 SEM of all
data). We also measured rates of transepidermal water
loss in vivo at the skin surface of 6-d-old pups with an
electrolytic water analyzer. Transgenic mice displayed
significantly higher rates of water loss, 43 
 
6
 
 9 
 
3 
 
10
 
2
 
2
 
 mg/
cm
 
2
 
 per h (mean 
 
6
 
 SEM, 
 
n
 
 
 
5 
 
4), in comparison with non-
transgenic littermates, 18 
 
6
 
 2 
 
3 
 
10
 
2
 
2
 
 mg/cm
 
2
 
 per h (mean 
 
6
 
SEM, 
 
n
 
 
 
5 
 
3).
 
Analysis of Epidermal Ultrastructure of 
Involucrin-Dsg 3 Mice 
 
The epidermal nucleated cell layers of the living epidermis
showed comparable normal ultrastructure, including des-
mosomal substructure, in transgenic and nontransgenic lit-
termates. However, the epidermal stratum corneum of
transgenic animals differed strikingly from that of nontrans-
genic littermates. Normally, with the transition from the
stratum granulosum to the stratum corneum, and then,
again, in the superficial stratum corneum, the desmosome
changes structure (Menon and Elias, 1997; Fartasch et al.,
1993). In the nucleated layer, it is seen as two opposing
dense plaques within the cell with an electron lucent center.
In the stratum corneum, it abruptly becomes an electron
dense intercellular structure (Fig. 5 B, arrows). In the nor-
mal stratum corneum, these desmosomal structures are well
maintained with closely opposed cells until near the surface
of the skin when the desmosomal structures degenerate and
the corneocytes separate (Odland, 1991). In contrast to this
normal structure, at the stratum granulosum–stratum cor-
neum interface and extending to the lowermost stratum cor-
neum in transgenic mice, we noted premature dissolution of
desmosomes with early cleft formation between adjacent
corneocytes (compare Fig. 5, A with B). This finding in the
transgenic epidermal stratum corneum was similar to the
early dissolution of desmosomes that occurs in stratum cor-
neum of normal oral mucous membrane (Fig. 5 C). Prema-
ture dissolution of desmosomes with cleft formation was
even more obvious in ruthenium tetroxide postfixed tissues,
where the relationship of the clefts to the extracellular
lamellar matrix could be appreciated (Fig. 6). These find-
ings are consistent with loss of barrier function from early
loss of corneocyte adhesion in these transgenic animals.
 
Tape Stripping of Epidermis Results in Increased Rate 
of Transepidermal Water Loss in Involucrin-Dsg 3 Mice
 
For further evidence of decreased corneocyte adhesion,
we measured protein obtained with serial tape stripping of
the stratum corneum in transgenic mice and normal litter-
mates, a standard measure that correlates with corneocyte
adhesion (Reed et al., 1995; Dreher et al., 1998)
 
.
 
 For trans-
genic mice, the rate of total protein obtained per tape
stripping was markedly increased up to six strippings, com-
pared with normal mice, where rate of total protein ob-
tained was increased for up to eight strippings (Fig. 7 A).
In these same animals, the increased rate of protein loss
from the stratum corneum of transgenics, compared with
normals, correlated with an accelerated rate of increase of
transepidermal water loss (Fig. 7 B). These findings are
consistent with the ultrastructural observations that show
decreased corneocyte adhesion. Taken together, the re-
sults suggest that expression of Dsg 3 throughout the epi-
dermis is associated with decreased adhesion of corneo-
cytes, resulting in increased transepidermal water loss
from an impaired epidermal barrier.
 
Expression of Dsg 3 in the Superficial Epidermis 
Does Not Affect Expression of Major 
Differentiation Markers 
 
To rule out the possibility that the expression of Dsg 3 in
the superficial epidermis might have major effects on mul-
tiple pathways of differentiation in the epidermis, we de-
Figure 6. Desmosomal dissolution results in lacunae within ex-
tracellular lamellar matrix in the stratum corneum. (A and B)
Transformation of secreted lamellar body contents into lamellar
membrane bilayers (arrows) begins at the SG–SC interface. Pre-
mature desmosome dissolution results in clefts (*) within the
lamellar membranes. (C) Control stratum corneum shows normal-
appearing desmosomes (D) within the lamellar bilayer system
(arrow). Bar: 0.25 mm. Ruthenium tetroxide postfixation. 
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termined expression of loricrin, involucrin, filaggrin, and
K10 in the transgenic and normal epidermis by Western
blotting (Fig. 8). There were no major changes seen in the
expression of these differentiation molecules. These data
show that the expression of Dsg 3 in the superficial epider-
mis does not cause a generalized perturbation in the over-
all differentiation of epidermis, although we cannot rule
out more subtle changes.
 
Discussion
 
Desmogleins play a major role in stabilizing cell–cell adhe-
sion in the living layers of the epidermis. This function is
perhaps best illustrated in the disease pemphigus in which
autoantibodies against these transmembrane glycoproteins
of the desmosome cause blisters due to loss of keratinocyte
adhesion. Although desmogleins provide this critical func-
tion, it is not clear why different desmoglein isoforms are
expressed at different levels in various stratified squamous
epithelia. To address this issue, we constructed transgenic
mice that expressed Dsg 3 throughout the entire epidermis,
as occurs in normal oral mucous membrane, in contrast to
its normal expression only in the deep epidermis. These
mice displayed a dramatic phenotype, characterized by
scaling shortly after birth, dehydration (usually leading to
lethality within the first 10 d of life), a histologically abnor-
mal epidermal stratum corneum, decreased adhesion of
corneocytes, and increased transepidermal water loss.
 
This phenotype was unlikely to be due to toxicity of
transgene overexpression, because the ratio of Dsg 3 to
Dsg 1 in transgenic epidermis approximated that in nor-
mal oral mucous membrane (i.e., tongue). Although this
ratio was somewhat higher than in tongue, at least in
founder 2, the transgenic tongue had Dsg 3 to Dsg 1 ratios
even higher than those of normal mucous membrane and
transgenic epidermis, yet did not show any gross abnor-
malities indicative of toxicity. In addition, the function and
processing of the transgenic Dsg 3 seems normal. For ex-
ample, we know that the transgenic Dsg 3 is expressed on
the cell surface, does not accumulate in the cytoplasm (as
it might in severe overexpression), and provides physio-
logic functional adhesion, because it compensates for loss
of Dsg 1 adhesion in pemphigus foliaceus (Wu et al.,
2000). Furthermore, there is no histologic or ultrastruc-
tural evidence of any dominant-negative effect on normal
desmosome formation in the nucleated epidermis, which
might be expected if there were toxicity from overexpres-
sion. Finally, the transgenic phenotype is not due to some
toxic general perturbation of epidermal differentiation be-
cause there were no changes in expression of major kerati-
nocyte differentiation antigens in the transgenic mice.
Interestingly, changing the Dsg 3 to Dsg 1 ratio in trans-
genic epidermis to more closely approximate that seen in
mucous membranes results in an epidermal stratum cor-
neum that histologically and ultrastructurally resembles the
stratum corneum of mucosal epithelia. Furthermore, the
transgenic epidermal stratum corneum, like mucous mem-
brane (Lesch et al., 1989), shows increased water perme-
ability compared with normal epidermal stratum corneum.
These data demonstrate that the distribution of desmo-
somal isoforms within epidermis affects the structure and
function of the stratum corneum. How this occurs is sug-
gested by the ultrastructural studies of transgenic skin. In
normal stratum corneum, there is an orderly processing of
the desmosome, with gradual dissolution beginning about
two to three cell layers above the stratum granulosum–
stratum corneum interface and continuing to the surface
of the skin (Fartasch et al., 1993). These degraded desmo-
somes form lacunae (clefts) within the extracellular lamel-
lar lipid bilayers between corneocytes in the mid to super-
ficial stratum corneum (Menon and Elias, 1997). Under
certain circumstances (e.g., occlusion of the stratum cor-
neum), these lacunae can form an interconnected network
of hydrophilic pores through which water and other mole-
cules can diffuse. In transgenic stratum corneum, there is a
premature dissolution of the desmosomes, with resultant
Figure 7. Increased stratum corneum loss with tape stripping
correlates with increased transepidermal water loss in involucrin-
Dsg 3 mice. (A) Total protein as a function of number of tape
strippings of stratum corneum. (B) Transepidermal water loss
(TEWL) as a function of number of tape strippings. Transgenic
mice show higher rates of protein loss and higher acceleration of
TEWL than control mice with stratum corneum stripping.
Figure 8. Western blot of ma-
jor differentiation markers
from two different involucrin-
Dsg 3 mice (tg) and two
control littermates (wt) show
no consistent differences in
expression. Filaggrin expres-
sion was variable, probably
due to different amounts of
retained stratum corneum or
different efficiencies of ex-
traction. 
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lacunar cleft formation and corneocyte separation in the
deepest layers of the stratum corneum. It is reasonable to
assume that these changes disrupt the barrier. Consistent
with this explanation was our finding that tape stripping of
the stratum corneum of these transgenic mice, compared
with normal mice, demonstrated increased protein loss,
presumably reflecting decreased corneocyte adhesion, as-
sociated with increasing rates of transepidermal water loss.
Although it may first appear paradoxical that the histol-
ogy of transgenic epidermis, which shows premature disso-
lution of desmosomes, shows a compact lamellar stratum
corneum compared with the typical normal basket weave
pattern, there is no correlation between the latter pattern
and desmosome function or lack thereof. The histology of
stratum corneum is an artifact of processing (probably due
to loss of lipids and inability to rehydrate those areas with
routine processing), because fully rehydrated stratum cor-
neum shows closely opposed cells without gaps (Odland,
1991). However, what is clear is that keratinized mucous
membrane and transgenic epidermis typically show re-
markably similar histology (as well as ultrastructure) of
their stratum corneum, which is distinct from the pattern
of normal epidermal stratum corneum.
Together, these observations suggest that the ratio of
desmosome isoforms in the stratum corneum affects physi-
ologic desmosomal processing, which in turn regulates the
degree of corneocyte adhesion and barrier function. Ex-
actly how the expression of Dsg 3 in the stratum corneum
might affect desmosomal processing is not obvious, in part
because the mechanisms of desquamation in the stratum
corneum have not been well characterized. Perhaps the
phenotype we observe is simply a consequence of inher-
ently different adhesive functions of Dsg 3 and Dsg 1, such
that incorporation of both does not lend mechanical stabil-
ity to the junctions in the stratum corneum. However, how
this instability would lead to degradation of the desmo-
some is not clear. There are proteolytic and hydrolytic en-
zymes that are likely involved in regulating desquamation
in the stratum corneum, and at least some of these en-
zymes may concentrate around corneodesmosomes (Elias
et al., 1988; Ekholm et al., 2000) (also discussed in Far-
tasch et al., 1993). It may be that the composition of the
corneodesmosome could affect the clustering or activation
of some of these enzymes, thereby modifying rates of des-
mosomal destruction. Another possibility is that Dsg 3
may be more susceptible to proteolytic degradation, and
once degraded may have a dominant-negative effect on
the desmosome (Allen et al., 1996). However, it will re-
quire that we know more about the biochemical pathways
of corneodesmosome processing before we understand
how Dsg 3 accelerates it.
In summary, these studies not only demonstrate that the
distribution of isoforms of a desmosomal cadherin can have
dramatic effects on the major physiologic function of epider-
mis (i.e., permeability barrier formation), but also underscore
the importance of desmosomes in regulating that function.
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